Do the endocrine and subjective effects of d-fenfluramine predict response to selective serotonin reuptake inhibitors?

Do the endocrine and subjective effects of d-fenfluramine predict response to selective serotonin reuptake inhibitors?

Thirty drug-free depressed patients underwent double-blind, placebo-controlled, neuroendocrine testing with the serotonin (5-HT) releasing agent d-fenfluramine prior to receiving treatment with a selective serotonin reuptake inhibitor (SSRI) for 8 weeks. Compared to placebo, d-fenfluramine significa...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Park, S, Williamson, D, Cowen, P
Natura:	Journal article
Lingua:	English
Pubblicazione:	1995

Documenti analoghi

Selective serotonin reuptake inhibitors
Pubblicazione: (2004)

Selective serotonin reuptake inhibitors.
di: Geddes, J, et al.
Pubblicazione: (2004)

Effectiveness of selective serotonin reuptake inhibitors - Response
di: Barbui, C, et al.
Pubblicazione: (2008)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
di: Chad Compagner, et al.
Pubblicazione: (2021-01-01)

Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers.
di: Goodall, E, et al.
Pubblicazione: (1993)

Selective serotonin reuptake inhibitors and spermatogenesis
di: M. N. Korshunov, et al.
Pubblicazione: (2021-07-01)

Effect of pindolol on the prolactin response to d-fenfluramine.
di: Park, S, et al.
Pubblicazione: (1995)

Effect of lithium on the prolactin response to D-fenfluramine in healthy subjects.
di: Power, A, et al.
Pubblicazione: (1993)

Selective serotonin reuptake inhibitors in children and adolescents
di: Swiss Medical Weekly
Pubblicazione: (2002-08-01)

Selective serotonin reuptake inhibitors for fibromyalgia syndrome
di: Brian Walitt, et al.

Selective serotonin reuptake inhibitors and Alzheimer’s disease
di: Bernadette Mdawar, et al.
Pubblicazione: (2020-01-01)

Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction
di: Thanh Thanh L. Nguyen, et al.
Pubblicazione: (2021-01-01)

Prediction of selective serotonin reuptake inhibitor response using diffusion-weighted MRI
di: Christine eDelorenzo, et al.
Pubblicazione: (2013-03-01)

Selective Serotonin Reuptake Inhibitors for Treatment of Selective Mutism
di: Mazlum Çöpür, et al.
Pubblicazione: (2012-03-01)

5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.
di: Park, S, et al.
Pubblicazione: (1996)

Selective serotonin reuptake inhibitors. Drugs related to tricyclic antidepressants are a mixed bag.
di: Cowen, P, et al.
Pubblicazione: (1994)

Pharmacovigilance of serotonin reuptake inhibitors
di: Darpan Kaur, et al.
Pubblicazione: (2013-01-01)

Prescribing selective serotonin reuptake inhibitors in older age.
di: Topiwala, A, et al.
Pubblicazione: (2014)

Selective serotonin reuptake inhibitors and pharmacological resetting of the mind
di: Ion G. Motofei, et al.
Pubblicazione: (2024-04-01)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
di: Levent Cerit

The Role of Selective Serotonin Reuptake Inhibitors in Premature Ejaculation
di: Alka Aggarwal, et al.
Pubblicazione: (2017-08-01)

Selective serotonin reuptake inhibitors and risk for gastrointestinal bleeding
di: Batić-Mujanović Olivera, et al.
Pubblicazione: (2014-01-01)

Suicide attempt with selective serotonin reuptake inhibitor antidepressants
di: Sandra Cuenca Carcelén, et al.
Pubblicazione: (2021-01-01)

Machine Learning Tool for New Selective Serotonin and Serotonin–Norepinephrine Reuptake Inhibitors
di: Natalia Łapińska, et al.
Pubblicazione: (2025-01-01)

Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis
di: Boyu Tan, et al.
Pubblicazione: (2024-07-01)

Decreased Growth with Serotonin Reuptake Inhibitors
di: J Gordon Millichap
Pubblicazione: (2002-08-01)

Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment.
di: Mccabe, C, et al.
Pubblicazione: (2010)

Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment
di: McCabe, C, et al.
Pubblicazione: (2010)

THE EFFECTS OF DIETING ON D-FENFLURAMINE INDUCED PROLACTIN RESPONSE
di: Walsh, A, et al.
Pubblicazione: (1993)

Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
di: Orna Diav-Citrin, et al.
Pubblicazione: (2012-01-01)

Ankle edema after administration of selective serotonin reuptake inhibitors
di: Konstantinos Kontoangelos, et al.
Pubblicazione: (2018-06-01)

Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment
di: Kuznecova LV, et al.
Pubblicazione: (2011-06-01)

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
di: Jeffrey R. Strawn, et al.
Pubblicazione: (2021-10-01)

EFFICACY OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH PREMATURE EJACULATION
di: Muhammed Muhammed, et al.
Pubblicazione: (2020-12-01)

Review of sexual dysfunction due to selective serotonin reuptake inhibitors
di: P Srilakshmi, et al.
Pubblicazione: (2012-01-01)

Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine
di: Kobayashi Katsunori, et al.
Pubblicazione: (2011-03-01)

Analytical methods for determination of selective serotonin reuptake inhibitor antidepressants
di: Şentürk Zühre, et al.
Pubblicazione: (2011-06-01)

Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor.
di: Bhagwagar, Z, et al.
Pubblicazione: (2004)

The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials
di: Marzieh Azizi, et al.
Pubblicazione: (2022-05-01)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
di: Natan Pereira Gosmann, et al.
Pubblicazione: (2021-06-01)